Lundbeck to acquire Longboard Longboard is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. Iterum Therapeutics receives FDA OK for OrlynvahOrlynvah is used to treat uncomplicated urinary tract infections caused by certain microorganisms in adult women who have limited or no alternative oral antibacterial treatment options. Tris Pharma intros Onyda XR Onyda XR is a liquid non-stimulant ADHD medication available in the United States. Amneal rolls out Crexont Crexont extended-release capsules are used to treat Parkinson’s disease. FDA approves Roche’s Ocrevus Zunovo with Halozyme’s Enhanze drug delivery technology Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology is used for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. Johnson & Johnson obtains FDA OK for new indication for Tremfya Tremfya is now approved for the treatment of plaque psoriasis, active psoriatic arthritis and ulcerative colitis. The Vitamin Shoppe expands Whole Health Rx telehealth service into TRT The Vitamin Shoppe is expanding its telehealth services into TRT via a partnership with Marius Pharmaceuticals. FDA approves AstraZeneca’s Imfinzi in combination with chemotherapy Imfinzi is used for the treatment of resectable non-small cell lung cancer before and after surgery. Hikma’s Kloxxado Naloxone Nasal Spray shelf-life extended The shelf-life of Kloxxado (naloxone HCl) nasal spray 8 mg has been extended from 24 to 36 months. FDA approves first nasal spray for anaphylaxis ARS Pharmaceutical's Neffy is used for the emergency treatment of life-threatening allergic reactions in adult and pediatric patients. 1 2 3 4 5 Next Last
